8508 Preliminary results of the randomized phase II TREMPLIN study: TPF Induction chemotherapy followed by radiotherapy plus cisplatin or cetuximab
Y. Pointreau(Centre Hospitalier Universitaire de Nantes), G. Calais(Centre Hospitalier Universitaire de Tours), A Baudoux(Centre Hospitalier Universitaire de Nantes), C. Tuchais(Centre Hospitalier Universitaire de Nantes), Clément Sire(Centre National de la Recherche Scientifique), M. Alfonsi(Centre Hospitalier Universitaire de Nantes), Dominique de Raucourt, J.-L. Lefebvre(Centre Oscar Lambret), F. Rolland(Institut de Cancérologie de l'Ouest), É. Bardet(Centre de Recherche en Cancérologie et Immunologie Intégrée Nantes Angers)
Cited by 0
Related Papers
Chemotherapy with Preoperative Radiotherapy in Rectal Cancer
|New England Journal of Medicine|2006|2.7k
Larynx Preservation in Pyriform Sinus Cancer: Preliminary Results of a European Organization for Research and Treatment of Cancer Phase III Trial
|JNCI Journal of the National Cancer Institute|1996|1.3k
Fluorouracil-based adjuvant chemotherapy after preoperative chemoradiotherapy in rectal cancer: long-term results of the EORTC 22921 randomised study
|The Lancet Oncology|2014|727
Enhanced Tumorocidal Effect of Chemotherapy With Preoperative Radiotherapy for Rectal Cancer: Preliminary Results—EORTC 22921
|Journal of Clinical Oncology|2005|593
Induction Chemotherapy Followed by Either Chemoradiotherapy or Bioradiotherapy for Larynx Preservation: The TREMPLIN Randomized Phase II Study
|Journal of Clinical Oncology|2013|418